These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 25086280)

  • 21. Ovarian reserve test: an impartial means to resolve the mismatch between chronological and biological age in the assessment of female reproductive chances.
    Gizzo S; Andrisani A; Esposito F; Oliva A; Zicchina C; Capuzzo D; Gangemi M; Nardelli GB
    Reprod Sci; 2014 May; 21(5):632-9. PubMed ID: 24155065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-Müllerian hormone exhibits a great variation in infertile women with different ovarian reserve patterns.
    Gorkem U; Kucukler FK; Togrul C; Gungor T
    Aust N Z J Obstet Gynaecol; 2017 Aug; 57(4):464-468. PubMed ID: 28419409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AMH and AMHR2 polymorphisms and AMH serum level can predict assisted reproduction outcomes: a cross-sectional study.
    Peluso C; Fonseca FL; Gastaldo GG; Christofolini DM; Cordts EB; Barbosa CP; Bianco B
    Cell Physiol Biochem; 2015; 35(4):1401-12. PubMed ID: 25790842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The dynamics of serum anti-Mullerian-hormone levels during controlled ovarian hyperstimulation with GnRH-antagonist short protocol in polycystic ovary syndrome and low responders.
    Weintraub A; Margalioth EJ; Chetrit AB; Gal M; Goldberg D; Alerhand S; Eldar-Geva T
    Eur J Obstet Gynecol Reprod Biol; 2014 May; 176():163-7. PubMed ID: 24630573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ovarian reserve and PGD treatment outcome in women with myotonic dystrophy.
    Srebnik N; Margalioth EJ; Rabinowitz R; Varshaver I; Altarescu G; Renbaum P; Levi-Lahad E; Weintraub A; Eldar-Geva T
    Reprod Biomed Online; 2014 Jul; 29(1):94-101. PubMed ID: 24813161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is the measurement of anti-Müllerian hormone essential?
    Usta T; Oral E
    Curr Opin Obstet Gynecol; 2012 Jun; 24(3):151-7. PubMed ID: 22487725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of anti-Müllerian hormone assessment in assisted reproductive technology outcome.
    Broer SL; Mol B; Dólleman M; Fauser BC; Broekmans FJ
    Curr Opin Obstet Gynecol; 2010 Jun; 22(3):193-201. PubMed ID: 20407372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Basal serum anti-Mullerian hormone (AMH) is a promising test in prediction of occurrence of pregnancy rate in infertile women undergoing ICSI cycles.
    Kamel HM; Amin AH; Al-Adawy AR
    Clin Lab; 2014; 60(10):1717-23. PubMed ID: 25651719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-Müllerian Hormone and Ovarian Reserve: Update on Assessing Ovarian Function.
    Moolhuijsen LME; Visser JA
    J Clin Endocrinol Metab; 2020 Nov; 105(11):3361-73. PubMed ID: 32770239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Anti-Müllerian hormone is a clinical useful measure of the ovarian reserve].
    Hyldgaard JM; Ingerslev HJ; Tørring N; Madsen HN; Bor P
    Ugeskr Laeger; 2015 Jan; 177(5):V09140477. PubMed ID: 25650516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of age and antimullerian hormone in assisted reproductive technology program outcome.
    Himabindu Y; Gopinathan KK; Pandey AK; Sriharibabu M
    Indian J Physiol Pharmacol; 2013; 57(1):9-15. PubMed ID: 24020093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utility of age-specific serum anti-Müllerian hormone concentrations.
    Barad DH; Weghofer A; Gleicher N
    Reprod Biomed Online; 2011 Mar; 22(3):284-91. PubMed ID: 21269880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-Mullerian Hormone Assessment in Assisted Reproductive Technique Outcome and Natural Conception.
    Sellami I; Barbotin AL; Bernard V; Robin G; Catteau-Jonard S; Sonigo C; Peigné M
    Semin Reprod Med; 2024 Mar; 42(1):25-33. PubMed ID: 39025077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.
    Elgindy EA; El-Haieg DO; El-Sebaey A
    Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
    Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
    Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Random anti-Müllerian hormone (AMH) is a predictor of ovarian response in women with elevated baseline early follicular follicle-stimulating hormone levels.
    Buyuk E; Seifer DB; Younger J; Grazi RV; Lieman H
    Fertil Steril; 2011 Jun; 95(7):2369-72. PubMed ID: 21497340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of anti-Müllerian hormone in female fertility and infertility - an overview.
    Grynnerup AG; Lindhard A; Sørensen S
    Acta Obstet Gynecol Scand; 2012 Nov; 91(11):1252-60. PubMed ID: 22646322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-Müllerian hormone versus antral follicle count for defining the starting dose of FSH.
    Lan VT; Linh NK; Tuong HM; Wong PC; Howles CM
    Reprod Biomed Online; 2013 Oct; 27(4):390-9. PubMed ID: 23953069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-Müllerian hormone as an ovarian reserve marker in young cancer women who undergo ovarian tissue cryopreservation.
    Fabbri R; Macciocca M; Melotti C; Pasquinelli G; Vicenti R; Bacchi Reggiani ML; Terribile D; Venturoli S
    Future Oncol; 2014 Jun; 10(8):1343-51. PubMed ID: 25052745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum level of anti-mullerian hormone in early follicular phase as a predictor of ovarian reserve and pregnancy outcome in assisted reproductive technology cycles.
    Dehghani-Firouzabadi R; Tayebi N; Asgharnia M
    Arch Iran Med; 2008 Jul; 11(4):371-6. PubMed ID: 18588367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.